Physician

Christopher Albert Peters, MD

According to 2025 Medicare claims, Christopher Peters, MD (NPI: 1487831673) practices radiation oncology in the Scranton--Wilkes-Barre, PA market, with the plurality of this provider's patient population coming from Luzerne, PA. This provider's primary affiliated billing organization is NORTHEAST RADIATION ONCOLOGY CENTER (NPI: 1891794467; TIN: 562401588) and primary practice location at 18512-3169. Peters is affiliated with the Keystone ACO (ACO ID: A1552), participating under the MSSP model.

Peters' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 795 traditional Medicare patients, billed 14,416 HCPCS/CPT codes, and received $2,391,152 in Medicare payments. The top billing code was 77290 (Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved). Part D data shows 282 prescription claims across 111 beneficiaries totaling $13,116 in drug costs, led by Myrbetriq (Mirabegron). 2022 DME data shows 26 claims. Open Payments data shows 18 records totaling $3,987. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,171,939 to $2,391,152. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,544 and ending at $13,116. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	546	7,056	$1,171,939
2016	624	6,913	$1,127,122
2017	639	7,961	$1,160,494
2018	653	9,543	$1,186,768
2019	611	7,034	$962,036
2020	625	10,459	$1,333,180
2021	639	7,830	$1,101,275
2022	653	8,947	$1,115,059
2023	720	11,263	$1,695,540
2024	795	14,416	$2,391,152

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	62	161	$3,544
2016	88	254	$7,221
2017	92	288	$5,708
2018	97	265	$5,185
2019	84	247	$5,879
2020	68	236	$4,909
2021	95	293	$5,861
2022	103	270	$4,650
2023	102	261	$7,342
2024	111	282	$13,116

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	23	$2,545
2019	N/R	25	$2,933
2020	N/R	12	$856
2021	N/R	24	$2,325
2022	N/R	26	$2,438
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77290	Obtaining data needed to develop the optimal radiation treatment, 3 or more treatment areas or any number of treatment areas where special treatment is involved	139	148	$323
77263	Complex radiation therapy planning	153	182	$127
77334	Design and construction of complex radiation treatment device	142	325	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	207	279	$87
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	311	395	$58

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Myrbetriq	Mirabegron	13	546	$7,936
Tamsulosin Hcl	Tamsulosin Hcl	107	6,875	$3,057
Dexamethasone	Dexamethasone	26	1,046	$533
Methylprednisolone	Methylprednisolone	31	188	$199
Levothyroxine Sodium	Levothyroxine Sodium	24	1,530	$139

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	18	$3,987	Accuray Incorporated
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Albert Peters, MD?

Tedicare shows public-source Medicare data for Christopher Albert Peters, MD (NPI 1487831673), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Albert Peters, MD have ACO affiliation data?

Christopher Albert Peters, MD is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552).

What billing organization is linked to Christopher Albert Peters, MD?

Christopher Albert Peters, MD is linked to NORTHEAST RADIATION ONCOLOGY CENTER (billing NPI 1891794467) in the available physician profile data.

Does Christopher Albert Peters, MD have Open Payments data?

Christopher Albert Peters, MD has 18 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.